Seres Therapeutics, Inc. Comparables
Find the most relevant public market comparables for Seres Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Seres Therapeutics, Inc. is a clinical-stage company focused on improving patient outcomes in medically vulnerable populations through novel live biotherapeutics. The company develops and researches ecobiotic microbiome therapeutics designed to restore health by repairing the function of a dysbiotic microbiome. They focus on treating dysbiosis in the colonic microbiome.
Business Model
Developing and commercializing live biotherapeutic products targeting various medical conditions, primarily focusing on microbiome therapeutics.
Target Customers
Medically vulnerable populations, including patients undergoing allogeneic hematopoietic stem cell transplants (allo-HSCT), those with recurrent Clostridium difficile infection (CDI), ulcerative colitis, metastatic melanoma, and other conditions.
Specific Focus
Development of live biotherapeutics to treat diseases through modulation of the microbiome.
Location
Cambridge, Massachusetts
CEO
Eric Shaff
Industry
Life sciences
Sub Sector
Microbiome Therapeutics
3yr Revenue Growth
280%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Seres Therapeutics, Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Seres Therapeutics, Inc.? Our platform provides detailed analysis of Seres Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Seres Therapeutics, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Seres Therapeutics, Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, Seres Therapeutics, Inc. operates in the specialized Microbiome Therapeutics sub-sector. Understanding how Seres Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Microbiome Therapeutics space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Seres Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free